• 1.

    Landsman, AS, AH Robbins, PF Angelini, et al. :Treatment of mild, moderate, and severe onychomycosis using 870-and 930-nm light exposure. .JAPMA 100::166. ,2010. .

    • Search Google Scholar
    • Export Citation
  • 2.

    Scher, RK, A Tavakkol, B Sigurgeirsson, et al. :Onychomycosis: diagnosis and definition of cure. .J Am Acad Dermatol 56::939. ,2007. .

    • Crossref
    • PubMed
    • Web of Science
    • Search Google Scholar
    • Export Citation
  • 3.

    Joseph, WS. :Why it’s essential to treat onychomycosis as an infection. .Podiatry Today 17::4. ,2004. .

Treatment of Mild, Moderate, and Severe Onychomycosis Using 870- and 930-nm Light Exposure

Some Follow-up Observations at 270 Days

View More View Less
  • 1 Division of Podiatric Surgery, Cambridge Health Alliance, Cambridge, MA.
  • | 2 Nomir Medical Technologies Inc, Brooklyn, NY. Dr. Robbins is now with the Department of Radiology, Beth Israel Deaconess Hospital, Boston, MA and the Department of Radiology, Tufts University, Boston, MA.
Restricted access

We have previously reported the results of a clinical trial in which the Noveon laser was used to treat onychomycosis. In the 180-day follow-up therein it was noted that positive clinical impact was demonstrable by a clearly measurable decrease in positive fungal culture and a concomitant decrease in positive microscopy with periodic acid-Schiff–stained nail scrapings. Review of 270-day mycological data, which are now available, confirmed that there was further decrease in both measures. Indeed, 38% of the treated population had negative culture and microscopy, qualifying as “mycological cures.” These mycological cures occurred in cases categorized as mild, moderate, and even severe disease. (J Am Podiatr Med Assoc 102(2): 169–171, 2012)

Corresponding author: Adam Landsman, DPM, PhD, Division of Podiatric Surgery, Harvard Medical School/ Cambridge Health Alliance, 1493 Cambridge St, Cambridge, MA 02139. (E-mail: alandsman@cha.harvard.edu)